SRTS
$3.98+0.01 (+0.38%)
Sensus Healthcare, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...
Recent News
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations
Sensus Healthcare’s analyst narrative has shifted, with one price target now set at US$7.50 and another adjusted to US$6 from US$8. Supportive research ties the US$7.50 view to confidence in the SRT-100/Vision platform and potential reimbursement changes in 2026. In contrast, more cautious voices cite recent quarterly weakness and customer concentration as reasons for the lower US$6 stance. As you read on, you will see how these differing targets shape the evolving story around expectations...
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
As you might know, Sensus Healthcare, Inc. ( NASDAQ:SRTS ) last week released its latest full-year, and things did not...
Sensus Healthcare, Inc. Q4 2025 Earnings Call Summary
Moby summary of Sensus Healthcare, Inc.'s Q4 2025 earnings call
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
Sensus Healthcare Inc (SRTS) outlines its path to profitability in 2026 amid revenue declines and increased international demand.
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company’s growth outlook heading into 2026. Executives highlighted newly established, dedicated CPT codes for the